Mon, August 14, 2023
Sun, August 13, 2023
Fri, August 11, 2023
Thu, August 10, 2023

Matt O"Brien Maintained (APYX) at Buy with Increased Target to $4.5 on, Aug 11th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-4-5-on-aug-11th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matt O"Brien of Piper Sandler, Maintained "Apyx Medical Corporation" (APYX) at Buy with Increased Target from $4 to $4.5 on, Aug 11th, 2023.

Matt has made no other calls on APYX in the last 4 months.

There are 3 other peers that have a rating on APYX. Out of the 3 peers that are also analyzing APYX, 1 agrees with Matt"s Rating of Hold. Following is the relevant analyst calls for the last 4 months;

David Turkaly of "JMP Securities" Reiterated at Hold on, Wednesday, May 24th, 2023

These are the ratings of the 2 analyists that currently disagree with Matt;

George Sellers of "Stephens & Co." Initiated at Buy and Held Target at $8 on, Friday, July 14th, 2023
Frank Takkinen of "Lake Street" Maintained at Strong Buy with Increased Target to $9 on, Thursday, June 15th, 2023


Publication Contributing Sources